novo nordisk glp 1 agonist GLP-1 RA education Ozempic's patent problem: how Novo

Osteochondroma is attributed to a congenital cause, although the patient may recall a traumatic event that brings a formally asymptomatic lesion to their attention

Baartscheer A, Schumacher CA, Wust RC, Fiolet JW, Stienen GJ, Coronel R, Zuurbier CJ (2017) Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits

A neuronal group theory of sleep function

This condition typically resolves on its own but may require warm compresses and temporary discontinuation of IV therapy at that site

Tesamorelin is a synthetic 44-amino-acid GHRH analog with a trans-3-hexenoic acid modification at the N-terminus and an extended plasma half-life, FDA-approved as Egrifta for visceral adipose tissue reduction in HIV-associated lipodystrophy